Terminalia avicennioides Guill. & Perr. (Combretaceae) is used traditionally to treat malaria in Nigeria. To establish its efficacy, methanolic extract of T. avicennioides bark was investigated for antimalarial activity against Plasmodium berghei (NK-65) in mice. Twenty-five mice in five groups were used for this study. Group 1 was uninfected normal control. Twenty mice infected with P. berghei were grouped as untreated negative control (group 2), 5 mg/kg b.w. p.o. artesunate-treated positive control (group 3), and 100 and 200 mg/kg b.w. p.o. T. avicennioides-treated infected mice (groups 4 and 5, respectively). Four-day suppressive effects on P. berghei and hematological and oxidative statuses of the mice were assessed. Suppression of parasitemia by artesunate and methanolic extract of T. avicennioides (at 100 and 200 mg/kg b.w.) after 1 day of treatment was 10, 18, and 11% respectively; at day 5, the level of suppression was 77, 82, and 84% respectively. P. berghei infection decreased hemoglobin, red blood cell, and lymphocyte counts and increased neutrophil count; artesunate and medicinal plant treatment restored these parameters to normal control levels. Also, artesunate and medicinal plant treatment of infected mice significantly (p < 0.05) increased serum and liver superoxide dismutase activities and significantly (p < 0.05) reduced serum malondialdehyde concentration compared to untreated infected mice. The antimalarial effect of T. avicennioides is comparable to that of artesunate. The restoration of oxidative and hematological statuses, to normal values by T. avicennioides, may provide better protection against the malaria severity and complications.

No abstract

Background: The leaves and stem bark of Anogeissus leiocarpa (DC.) Guill. & Pirr. (Combretaceae) are commonly included in recipes used for the management of sickle cell disease in western part of Nigeria. Objective: The present study was carried out to evaluate the potential of methanol extract and various fractions of A. leiocarpa leaves and stem bark to inhibit as well as reverse sodium metabisulphite induced polymerization of sickle cell haemoglobin. Method: The modified Emmel test was used to evaluate the inhibitory activity and the reversal effects of the extracts and fractions of both the leaves and the stem bark of A. leiocarpa in vitro. Results: Both the leaves and the stem bark extracts of A. leiocarpa were effective at inhibiting as well as reversing sodium metabisulphite induced polymerization of sickle cell haemoglobin, though the activity was higher in the leaves (94.52 ± 0.80% and 95.67 ± 0.67% respectively) when compared with the stem bark (51.79 ± 2.46 % and 50.45 ± 3.18 % respectively). The ethyl acetate fraction of both leaves and stem bark also gave good activities in both test methods with percentage reversal of 82.74 ± 1.82% and 67.63 ± 2.18% respectively. Conclusions: : A. leiocarpa extracts and ethyl acetate fractions exhibit good inhibition and reversal of sodium metabisulphite–induced polymerization of sickle cell haemoglobin thus justifying its inclusion in remedies used for the traditional management of sickle cell.

Aims: Bambusa tuldoides cv. ventricosa (bamboo) extract is used locally in the treatment of different types of fever in Africa. The extraction by cooking of fresh bamboo leaves using fermented steep liquor of ogi either made from maize or sorghum has been used traditionally in the treatment of Typhoid fever in the SouthWestern Nigeria. This work is designed to evaluate the antibacterial activity of the different fermented cereal (Zea mays and Sorghum bicolor) grains steep liquors as the extraction medium for the bamboo leaf in comparison with the ethanol extraction using agar well diffusion. Methodology and results: The extracted leaves (dried and fresh) from different fermented cereal steep liquors [maize (white and yellow) and sorghum (white and red)] media were screened for inhibition of some pathogenic species such as Staphylococcus aureus, Salmonella typhi, Streptococcus faecalis and Escherichia coli. The extracts were then tested at different concentrations for bacteriostatic activity towards these clinically-important species. The fresh leaf extracts from the fermented maize and sorghum liquors at a concentration of 20 g/100 mL showed antibacterial activities for all the tested bacteria, while the ethanolic leaf extract did not show any antibacterial activity for both S. typhi and S. faecalis. Higher concentration (20 g/ 40 mL) produced higher antibacterial activity in all the leaf extracts from the fermented maize and sorghum liquors. Conclusion, significance and impact study: Our data provide support for the traditional use of fermented maize and sorghum grill steep liquor extract of Bambusa tuldoides cv. ventricosa in treating the symptoms associated with the test organisms, in which the yellow maize liquor displayed greater antibacterial activity in comparison with the others.

Medicinal plants have been used traditionally in Africa, especially Nigeria, in the management of sickle cell disorder (SCD) whose treatment has been mainly palliative. The antisickling properties of ethanol extract of Telfairia occidentalis Hook, F. (TO) (Family Cucurbitaceae) leaf was tested in vitro at concentrations 1, 2, 4, 8 and 16 mg/mL using inhibitory and reversal models. Nitrogen gas was used to induce hypoxia for 1 h. The effect of TO on red cell density and cell membrane were also determined. The methanol sub fraction of TO extract was subjected to GC/MS to identify some of the active compounds. The TO gave antisickling activities of 78.84 ± 1.34% inhibition and 95.4 ± 0.81% reversal, which are significantly (p < 0.05) higher than that of Ciklavit®. The TO extract gave a change in density of 17.83 ± 0.77% and a dose dependent activity on RBC membrane. Methyl 9-cis 11- trans-octadecadienoate; 1, 4- benzenedicarboxylic acid; 9, 12-octadecadienoic acid (Linoleic acid); and hexadecanoic acid methyl ester (palmitic acid); were identified from TO ethanol leaf extract for the first time using GC/MS. This study authenticated the ethnomedicinal claims of the use of T. occidentalis in the management of sickle cell disorder.